David Berry - Profile and Investment Details

Investor Profile

David Berry is a Venture Capital based in Cambridge, Massachusetts, United States with a diverse investment portfolio that includes companies such as KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals, Incredible Foods, Inzen Therapeutics, Hackley School, Ohana Biosciences, T2 Biosystems, Tangent Medical Technologies, Kaleido BioSciences, Permeon Biologics, Kovio, Oasys Water, Editas Medicine, Tessera Therapeutics, Ring TherapeuticsModerna Therapeutics, Omega Therapeutics, Cygnal Therapeutics, Sana Biotechnology, Seres Therapeutics, Agios Pharmaceuticals, Red Rock Biofuels, Tarveda Therapeutics, Receptos, Repertoire Immune Medicines, Generate Biomedicines, Codiak Biosciences, BlackDuck, Polatis, Seventh Sense Biosystems, Sigilon Therapeutics, Boragen, TARIS Biomedical, TransMedics, Selecta Biosciences, Boston Philharmonic Orchestra, Quanterix, Visterra, Sesen Bio, Inc., CiBO Technologies, medidametrics, Rubius Therapeutics, Axcella, Senda Biosciences, Foghorn Therapeutics, Evelo Biosciences, Inari, Joule Unlimited Technologies, Cellarity, WikiCell Designs, Avedro, Indigo, EcoSense Lighting, Valo Health, Invaio Sciences, . Over time, David Berry has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether David Berry is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Women Founded, Life Science, Biotechnology, Hispanic / Latinx Founded, Clean Technology, Groceries, Agriculture, Oil and Gas, Medical, Therapeutics, Pharmaceuticals may find it worthwhile to explore potential connections with David Berry, as their portfolio suggests a familiarity and interest in this area.

Understanding David Berry’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.